Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion type Assertion NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_head.
- NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion description "[In light of the increasing use of G-CSF and GM-CSF in adjuvant tumor therapy, our data, as well as those discussed for head-and-neck tumors and gliomas, warrant a careful re-evaluation of the clinical application of both factors.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_provenance.
- NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion evidence source_evidence_literature NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_provenance.
- NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion SIO_000772 10597195 NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_provenance.
- NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion wasDerivedFrom befree-20140225 NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_provenance.
- NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_assertion wasGeneratedBy ECO_0000203 NP208267.RAw29IRzbBxjTYyyszCGRmmLFU0uSVO_G-GSBJg4VWa24130_provenance.